Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-21-003788

EVP, Drug Development gave up 433 shares (to pay taxes)

  • EVP, Drug Development acquired 1,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
MANHARD KIMBERLY EVP, Drug Development 2021-01-13 Option exercise +1,250 1,250 D: show line 1 in the form
MANHARD KIMBERLY EVP, Drug Development 2021-01-13 Shares withheld for taxes −433 $18.16 $7,863 817 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
MANHARD KIMBERLY EVP, Drug Development 2021-01-13 Option exercise · Restricted Stock Units −1,250 18,750 D: show line 3 in the form
Loading xslF345X03/doc4.xml…